Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid Tumors
Stanford University
Stanford University
British Columbia Cancer Agency
Cancer Research UK
Mayo Clinic
University of Southern California
Yale University